Research
Leerink Partners Initiates Coverage on Harrow With Outperform Rating, $45 Price Target
Harrow (HROW) has an average rating of buy and mean price target of $68.38, according to analysts polled by FactSet.
$HROW
$HROW
3 stories mentioning HROWUpdated 13d ago
Every FINWIRES story that references HROW, newest first.
What are analysts saying about HROW?
Recent broker actions mentioned in FINWIRES coverage. Compiled from wire headlines; not investment advice.
What's the latest news on HROW?
Insider Trading
Harrow Insider Bought Shares Worth $302,000, According to a Recent SEC Filing
Mark L Baum, Director and Chief Executive Officer, on May 14, 2026, executed a purchase for 10,000 shares in Harrow (HROW) for $302,000. Following the Form 4 filing with the SEC, Baum has control over a total of 2,996,130 common shares of the company, with 2,996,130 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1360214/000149315226023321/xslF345X05/ownership.xml
$HROW
Wire
Harrow Taps LogiCare3PL as Distribution Partner
Harrow (HROW) has chosen logistics company LogiCare3PL as its distribution partner for its portfolio of ophthalmic disease management offerings, LogiCare3PL said Tuesday.Financial terms of the partnership were not provided.The distribution agreement was effective Feb. 1, LogiCare3PL said.Price: $38.37, Change: $+1.27, Percent Change: +3.42%
$HROW
